leadf
logo-loader
ASX:MXC PINK:MGCLF LSE:MXC

MGC Pharmaceuticals Ltd

Receive alerts
Market:
ASX
Market Cap:
$196.14 m
Price
0.09 AUD
Change
-8.33%
52 weeks high
0.13
52 weeks low
0.02

In brief

MGC Pharmaceuticals Ltd (ASX:MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines.

Snapshot

The company is focused on its core business of executing its growth strategy and become a world-leading, vertically integrated, biopharma company focused on the development and production of phytocannabinoid derived medications for targeted global markets.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Roll up roll up: Cannabis companies queue up to join London's budding subsector

London's cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutants MGC Pharmaceuticals and Kanabo Group both warmly welcomed after listing this month

1 week, 3 days ago